Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Minerva Neurosciences Inc (NASDAQ: NERV)

 
NERV Technical Analysis
5
As on 23rd Oct 2025 NERV STOCK Price closed @ 4.87 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.47 & Strong Buy for SHORT-TERM with Stoploss of 2.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NERVSTOCK Price

Open 5.18 Change Price %
High 5.61 1 Day -0.51 -9.48
Low 4.84 1 Week 2.33 91.73
Close 4.87 1 Month 2.74 128.64
Volume 713750 1 Year 2.39 96.37
52 Week High 6.41 | 52 Week Low 1.34
 
NASDAQ USA Most Active Stocks
BYND 2.84 -20.67%
AMRS 0.14 100.00%
WBA 11.98 0.50%
TSLA 448.98 2.28%
LMDX 0.02 0.00%
INTC 38.16 3.36%
VTYX 6.60 70.98%
NVDA 182.16 1.04%
AKTS 0.04 0.00%
ADAP 0.07 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
EGRX 1.00 900.00%
CTXRW 0.14 600.00%
ORGS 0.90 260.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
AXAS 0.03 -70.00%
 
 
NERV
Daily Charts		 NERV
Intraday Charts		 Whats New @
Bazaartrend		 NERV
Free Analysis
 
NERV Important Levels Intraday
RESISTANCE6.35
RESISTANCE5.88
RESISTANCE5.58
RESISTANCE5.29
SUPPORT4.45
SUPPORT4.16
SUPPORT3.86
SUPPORT3.39
 
NERV Forecast October 2025
Share
4th UP Forecast7.63
3rd UP Forecast6.74
2nd UP Forecast6.2
1st UP Forecast5.65
1st DOWN Forecast4.09
2nd DOWN Forecast3.54
3rd DOWN Forecast3
4th DOWN Forecast2.11
 
NERV Weekly Forecast
4th UP Forecast5.24
3rd UP Forecast5.12
2nd UP Forecast5.05
1st UP Forecast4.97
1st DOWN Forecast4.77
2nd DOWN Forecast4.69
3rd DOWN Forecast4.62
4th DOWN Forecast4.50
 
NERV Forecast2025
4th UP Forecast26.66
3rd UP Forecast19.67
2nd UP Forecast15.35
1st UP Forecast11.03
1st DOWN Forecast-1.29
2nd DOWN Forecast-5.61
3rd DOWN Forecast-9.93
4th DOWN Forecast-16.92
 
 
NERV Other Details
Segment EQ
Market Capital 58528592.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NERV Address
NERV
 
NERV Latest News
 
Your Comments and Response on Minerva Neurosciences Inc
 
NERV Business Profile
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, a compound in Phase III clinical trial for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Address: 1601 Trapelo Road, Waltham, MA, United States, 02451
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service